IDNA · iShares

iShares Genomics Immunology and Healthcare ETF

See how 59 reported holdings combine into this ETF’s P/E and P/S. Market value, signed ordinary earnings and revenue are added before each ratio is calculated.

Holdings dated 21 August 2026Price US$41.65 as of 2 October 2026Coverage limitations apply

Core valuation

Trailing P/E-41.42×86.29% coverage

Latest-quarter run-rate P/E-67.35×86.29% coverage

Trailing P/S5.12×84.15% coverage

Latest-quarter run-rate P/S4.99×84.15% coverage

Coverage is the share of positive eligible-equity holding value represented in each metric. The published holdings account for 100.00% of fund weight. The reliability standard requires at least 90.00% disclosed fund weight and metric coverage, with no individual uncovered holding above 1.00%.

Largest reported holdings

Largest reported ETF holdings with weights and trailing valuation ratios
Holding	Weight	Trailing P/E	Trailing P/S
MRNAMODERNA INC	8.95%	-23.94×	33.86×
TWSTTWIST BIOSCIENCE	6.16%	-86.25×	27.31×
RVMDREVOLUTION MEDICINES	4.11%	-24.96×	Unavailable
GMAB.COGENMAB	3.99%	25.71×	5.41×
BAYN.DEBAYER AG	3.93%	-20.02×	0.95×
BNTXBIONTECH SE ADR	3.87%	-12.45×	7.92×
REGNREGENERON PHARMACEUTICALS	3.84%	17.99×	5.01×
MRKMERCK & CO INC	3.70%	111.82×	5.33×
INCYINCYTE CORP	3.65%	16.35×	4.37×
VRTXVERTEX PHARMACEUTICALS	3.59%	29.16×	10.20×

Top 10 of 59 reported holdings. * A holding uses its latest full-year result only when both trailing and latest-quarter inputs are unavailable; open the stock for the exact year end.

Most similar funds

Ranked by shared weight across matching disclosed company holdings and explicitly reported same-currency cash.

IBB · iShares Biotechnology ETF22.40% holdings overlap · US market
GNOM · Global X Genomics & Biotechnology ETF20.27% holdings overlap · Nasdaq
BBH · VanEck Biotech ETF19.33% holdings overlap · Nasdaq
XBI · State Street SPDR S&P Biotech ETF19.15% holdings overlap · NYSE Arca
BMED · iShares Health Innovation Active ETF18.12% holdings overlap · NYSE Arca

Sources and limitations

Holdings are sourced from iShares and company financial inputs retain primary-source links. Monetary values are normalised to USD. Corporate actions, reporting lags, unmapped securities and cash can create differences from provider figures.

Open official holdings source

Research holdings date: 21 August 2026. Informational research, not investment advice.